Medifast reports Q3 EPS 10c vs $2.12 last year
The Fly

Medifast reports Q3 EPS 10c vs $2.12 last year

Reports Q3 revenue $140.163M vs $235.869M last year. “Medical innovation has transformed the weight loss industry, so at Medifast (MED) we’re creating a health and wellness business of the future by meeting the unique needs of customers regardless of their approach to their health goals,” said Dan Chard, Chairman & CEO.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App